Search

everythinglearnresearchcommunity

for

Search:↓

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Obesity and negative body image harm mental health and quality of life in women with PCOS.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Three siblings with a genetic form of rickets showed different symptoms of the disease.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Bariatric surgery improves skin conditions and metabolism but may cause nutritional deficiencies and hair loss.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.